Novartis scoops up UK biotech Myricx in $1.5 billion cancer push

Novartis AG NVS has agreed to acquire privately held U.K. biotechnology company Myricx Bio in a deal valued at up to $1.5 ...
The Manila Times

PharmAla Completes GMP Manufacturing of Drug Substance components for ALA-002 Provides Corporate Update Regarding ALA-002 Asset

PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class ...
ZAWYA

Bateen World Academy continues to score above IB global averages with class of 2026 achieving outstanding results

Graduates earn places at world-leading universities across the UK, US, Europe, Australia, Hong Kong and the UAE Results ...
The Manila Times

Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients

Adds potential first-in-class,N-myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform, designed to address resistance to current payloads Strengthens the Novartis ...